ATE407139T1 - Neue inhibitoren der 17beta hydroxysteroid- dehydrogenase typ i - Google Patents

Neue inhibitoren der 17beta hydroxysteroid- dehydrogenase typ i

Info

Publication number
ATE407139T1
ATE407139T1 AT04804529T AT04804529T ATE407139T1 AT E407139 T1 ATE407139 T1 AT E407139T1 AT 04804529 T AT04804529 T AT 04804529T AT 04804529 T AT04804529 T AT 04804529T AT E407139 T1 ATE407139 T1 AT E407139T1
Authority
AT
Austria
Prior art keywords
hydroxysteroid dehydrogenase
dehydrogenase type
new inhibitors
17beta
17beta hydroxysteroid
Prior art date
Application number
AT04804529T
Other languages
English (en)
Inventor
Josef Messinger
Heinrich-Hubert Thole
Bettina Husen
Steen Bartholomeus Johannes Van
Gyula Schneider
Johannes Bernardus Everardus Hulshof
Pasi Koskimies
Nina Johansson
Jerzy Adamski
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of ATE407139T1 publication Critical patent/ATE407139T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04804529T 2003-11-12 2004-11-11 Neue inhibitoren der 17beta hydroxysteroid- dehydrogenase typ i ATE407139T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104169 2003-11-12
EP04105313 2004-10-26

Publications (1)

Publication Number Publication Date
ATE407139T1 true ATE407139T1 (de) 2008-09-15

Family

ID=34593637

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04804529T ATE407139T1 (de) 2003-11-12 2004-11-11 Neue inhibitoren der 17beta hydroxysteroid- dehydrogenase typ i

Country Status (21)

Country Link
EP (1) EP1685150B1 (de)
JP (1) JP4778438B2 (de)
KR (1) KR101070025B1 (de)
AR (1) AR046580A1 (de)
AT (1) ATE407139T1 (de)
AU (1) AU2004289459B2 (de)
BR (1) BRPI0416551A (de)
CA (1) CA2545704C (de)
DE (1) DE602004016373D1 (de)
DK (1) DK1685150T3 (de)
ES (1) ES2314478T3 (de)
HR (1) HRP20080603T3 (de)
IL (1) IL175220A (de)
NO (1) NO20062679L (de)
PL (1) PL1685150T3 (de)
PT (1) PT1685150E (de)
RU (1) RU2369614C2 (de)
SA (1) SA04250373B1 (de)
SI (1) SI1685150T1 (de)
TW (1) TWI331154B (de)
WO (1) WO2005047303A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004025966A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estradiol-Prodrugs
DE102004025985A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estriol- und Estetrol-Prodrugs
ES2388297T3 (es) * 2005-05-26 2012-10-11 Abbott Products Gmbh Inhibidores de 17-HSD1 y STS
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
CA2643670A1 (en) * 2006-02-27 2007-08-30 Sterix Limited Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
US8080540B2 (en) 2006-09-19 2011-12-20 Abbott Products Gmbh Therapeutically active triazoles and their use
JP5268917B2 (ja) * 2006-09-19 2013-08-21 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 治療学的に有効なトリアゾール類及びそれらの使用
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8288367B2 (en) 2006-11-30 2012-10-16 Solvay Pharmaceuticals Gmbh Substituted estratriene derivatives as 17BETA HSD inhibitors
CA2671075A1 (en) * 2006-11-30 2008-06-05 Solvay Pharmaceuticals Gmbh Substituted estratrien derivatives as 17beta hsd inhibitors
DE102007015169A1 (de) 2007-03-27 2008-10-02 Universität des Saarlandes Campus Saarbrücken 17Beta-Hydroxysteroid-Dehydrogenase-Typ1-Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
DE102007040243A1 (de) 2007-08-25 2009-02-26 Universität des Saarlandes 17Beta-Hydroxysteriod-Dehydrogenase Typ1 Inhibitoren zur Behandlung hormonabhängiger Erkrankungen
CN103180321A (zh) 2010-09-23 2013-06-26 Abbvie公司 氮杂金刚烷衍生物的一水合物
CA2830984C (en) 2011-03-25 2020-02-11 Universite Laval Inhibitors of 17.beta.-hsd1, 17.beta.-hsd3 and 17.beta.-hsd10.
BR112015031846A8 (pt) * 2013-06-25 2018-03-06 Forendo Pharma Ltd derivados de estratrientiazol, seus usos, e composição farmacêutica
JP6456373B2 (ja) 2013-06-25 2019-01-23 フォレンド ファーマ リミテッド １７β−ヒドロキシステロイドデヒドロゲナーゼ タイプ１の阻害剤として治療活性のあるエストラトリエンチアゾール誘導体
WO2014207309A1 (en) 2013-06-25 2014-12-31 Forendo Pharma Ltd Therapeutically active estratrienthiazole derivatives as inhibitors of 17 b-hydroxysteroid dehydrogenase, type 1
CN107207562B (zh) 2014-12-23 2020-03-06 佛恩多制药有限公司 17β-HSD1抑制剂的前药
EP3237431B1 (de) 2014-12-23 2019-03-20 Forendo Pharma Ltd Prodrugs von 17.beta.-hsd1-inhibitoren
CZ307437B6 (cs) 2016-06-07 2018-08-22 Ăšstav organickĂ© chemie a biochemie AV ÄŚR, v.v.i. 15β-substituované deriváty estronu jako selektivní inhibitory 17β-hydroxysteoiddehydrogenáz
MX391234B (es) 2017-06-08 2025-03-21 Forendo Pharma Ltd Compuestos de estra-1,3,5(10)-trien-17-ona sustituida con 15.beta.-[3-propanamido] y sus 17-oximas para usarse en la inhibicion de 17.beta.-hidroxiesteroides deshidrogenasas.
JP7417608B2 (ja) 2018-12-05 2024-01-18 フォレンド ファーマ リミテッド １７－ｈｓｄ１阻害剤としての１６（１７）位でピラゾール環と縮合しているエストラ－１，３，５（１０）－トリエン化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
GB0306718D0 (en) * 2003-03-24 2003-04-30 Sterix Ltd Compound

Also Published As

Publication number Publication date
JP4778438B2 (ja) 2011-09-21
DE602004016373D1 (de) 2008-10-16
HRP20080603T3 (en) 2009-03-31
KR101070025B1 (ko) 2011-10-04
SA04250373B1 (ar) 2009-12-22
CA2545704C (en) 2012-06-26
RU2369614C2 (ru) 2009-10-10
AU2004289459A1 (en) 2005-05-26
CA2545704A1 (en) 2005-05-26
IL175220A (en) 2010-12-30
KR20060121171A (ko) 2006-11-28
JP2007510697A (ja) 2007-04-26
EP1685150B1 (de) 2008-09-03
SA04250373A (ar) 2005-12-03
HK1099309A1 (en) 2007-08-10
AU2004289459B2 (en) 2010-08-19
SI1685150T1 (sl) 2008-12-31
WO2005047303A2 (en) 2005-05-26
WO2005047303A3 (en) 2005-08-25
IL175220A0 (en) 2006-09-05
PL1685150T3 (pl) 2009-02-27
TW200521133A (en) 2005-07-01
RU2006120488A (ru) 2008-01-10
AR046580A1 (es) 2005-12-14
DK1685150T3 (da) 2008-12-01
NO20062679L (no) 2006-08-10
ES2314478T3 (es) 2009-03-16
TWI331154B (en) 2010-10-01
PT1685150E (pt) 2008-11-12
BRPI0416551A (pt) 2007-02-27
EP1685150A2 (de) 2006-08-02

Similar Documents

Publication Publication Date Title
ATE407139T1 (de) Neue inhibitoren der 17beta hydroxysteroid- dehydrogenase typ i
DE602005011795D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
EP1788874A4 (de) Salze von 5-azacytidin
DK1562589T3 (da) Diaminotriazoler der er nyttige som inhibitorer af proteinkinaser
DK1789041T3 (da) Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer
ATE401893T1 (de) Thiophenepyrimidinone als 17-beta-hydroxysteroid dehydrogenase inhibitoren
EP1736516A4 (de) Antifoulinglack
ATE452631T1 (de) N-2-adamantanyl-2-phenoxy-acetamid-derivate als 11-betahydroxysteroid-dehydrogenase-hemmer
DK2039685T3 (da) Heterobicycliske forbindelser som P38-inhibitorer
DK1797042T3 (da) Indozolonderivater som 11B-HSD1-inhibitorer
EP1595926A4 (de) Beschichtungszusammensetzung
DK1709125T3 (da) Overtrækssammensætning med overfladerensende egenskaber
DK1664043T3 (da) Sammensætninger egnede som inhibitorer af proteinkinaser
DK1713806T3 (da) Forbindelser og sammensætninger som proteinkinaseinhibitorer
DE602004010873D1 (de) Phasenaustauschtintenzusammensetzungen
EP1788049A4 (de) Heisshärtbare wässrige beschichtungszusammensetzung
DK1763517T3 (da) Pyrimidinderivater som 11beta-HSD1-inhibitorer
DE602005014646D1 (de) Substituierte propenylpiperazinderivate als neue inhibitoren von histondeacetylase
DK1536796T3 (da) N-arylpiperidinsubstituerede biphenylcarboxamider som inhibitorer af apolipoprotein B-sektion
DK1817387T3 (da) Anvendelse af polysilazaner til belægning af metalbånd
NO20052193D0 (no) Korrosjonshemmende sammensetning
ATE545642T1 (de) Mmp-inhibitoren
DE112005003431A5 (de) Neuartige Inhibitoren der Lysyloxidase
NO20034109L (no) Parafininhibitor-komposisjon
DK1765832T3 (da) Hidtil ukendte oxabispidinforbindelser deres anvendelse til behandling af hjertearytmier

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1685150

Country of ref document: EP